Shares of MicroStrategy Inc. ($MSTR) attracted significant attention among investors on Stocktwits Thursday, becoming the platform’s top trending symbol after short ...

MicroStrategy (NASDAQ:MSTR) provides AI-powered enterprise ... Recently, it faced a setback in its stock performance after Citron Research announced its decision to bet against the company.

Citron Research identified Teladoc as a potential AI opportunity hiding in plain sight. While Teladoc's revenue has plateaued, its profitability has grown. The stock is quite cheap compared to ...

KBW analyst Bill Papanastasiou maintained a Buy rating on Strategy (MSTR – Research Report) today and set a price target of $560.00. The ...

Elsewhere in the tech space, MicroStrategy (MSTR) surged 6.2%, recovering from Thursday's sharp selloff. Sparking yesterday's slide was a tweet from Citron Research that said the prominent short ...

Investing.com -- Shares of Teladoc Health Inc (NYSE: NYSE:TDOC) climbed 6% after Citron Research, led by notable short seller Andrew Left, highlighted the company's potential in a recent report.

Last week, Citron Research made a splash after it labeled Teladoc Health (NYSE: TDOC) a hidden artificial intelligence (AI) opportunity that is still viewed by many as a "pandemic relic." ...